INTRODUCTION
Disorders of the IAS underlie many clinical abnormalities, including fecal incontinence, 1 and constipation. 2 Specifically, hypertensive IAS is associated with a number of gastrointestinal disorders such as Hirschsprung's disease, 3-5 recurrent anal fissures and hemorrhoids. 6, 7 Knowledge of the molecular mechanisms that underlie control of the IAS smooth muscle tone is essential to advance an understanding of the pathophysiology of these abnormalities and their therapeutic management.
The IAS tone is largely maintained by the unique properties of the smooth muscle (SM)
proper. 5, 8 It has been suggested that the basal tone in other sphincteric smooth muscle may be governed by Ca 2+ /MLCK or PKC pathways. [9] [10] [11] Recently, it has been recognized that the smooth muscle contraction in response to certain agonists occurs in two phases, an initial (phasic) and a later sustained (tonic). Ca 2+ /MLCK is critical in the initial phase while RhoA/ROK plays a major role in the sustained contraction. 10, 12, 13 To date, a number of approaches have been suggested to treat rectoanal motility disorders involving hypertensive IAS and incomplete relaxation. These are: Ca 2+ channel blockers, 14 NO donors, 15, 16 botulinum toxin, 17, 18 and specific phosphodiesterase (PDE) inhibitors such as Viagra. 19, 20 However, these approaches may lead to variable outcomes, prominent side effects (especially cardiovascular hypotension), and desensitization. In addition, these approaches may exert their final effects via other intracellular signal transduction pathways. For example, The PDE inhibitors prevent the breakdown of cGMP, 21 which in turn works via the inactivation of RhoA/ROK.
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The defecation reflex (anorectal inhibitory reflex) is mediated via the sacral nerves that impinge on the local myenteric nonadrenergic noncholinergic (NANC) inhibitory neurons Ms. No. GaASTRO-D-06-00128
(containing neuronal nitric oxide synthase or nNOS) within the IAS. 4, 5, 23 The loss of such neurons, 4, [24] [25] [26] may be associated with the hypertensive IAS and incomplete relaxation of the IAS. Therefore, the agents that bypass the NOS/cGMP pathway, work directly in the SMC, and have fewer systemic side effects, will be most desirable for the hypertensive IAS-associated motility dysfunctions.
The purpose of the present investigation therefore, is to determine the role of RhoA/ROK as the molecular bases for the genesis of basal tone in the IAS, and to explore ROK inhibitors as therapeutic potentials for the hypertensive IAS. Y 27632 has been recognized to be a selective ROK inhibitor both in vitro and in vivo settings. 25 NaHCO 3 , and 11.10 glucose (37ºC). Circular smooth muscle strips (~0.5 X 7 mm) of the IAS and the rectal smooth muscle (RSM) were prepared as explained previously 28 and transferred to 2-ml muscle baths containing oxygenated KPS at 37ºC. Isometric tension was measured via force transducers (model FT03; Grass Instruments, Quincy, MA) using the PowerLab/8SP dataacquisition system (AD Instruments, Australia) using Chart 5 (AD Instruments).
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MATERIALS AND METHODS
Materials and methods
29-31
The changes in basal IAS tone were expressed as % of maximal relaxation by 10 mM EDTA at the end of each experiment. 32 Ms. No. GaASTRO-D-06-00128
The experimental protocol of the study was approved by the institutional Animal Care and Use Committee of Thomas Jefferson University and was in accordance with the recommendations of the American Association for the Accreditation of Laboratory Animal Care.
Recording of Intraluminal Pressures of the IAS (IASP) and Mean Systolic Blood Pressure (MSBP).
The high pressure zone of the IAS was identified using slow station pull through, and IASP were monitored by the modified approach of Terauchi et al., 33 using solid-state catheter assembly (Millar Instruments, Houston, TX). For some studies, IASP were also monitored using custom-designed water-perfused catheter assembly (Arndorfer Inc., Greendale, WI) that consists of 25 cm long vinyl tube of three channels of a 0.3-mm inside and 0.6-mm outside diameter each.
MSBP was recorded via a non-invasive blood pressure measurement system (by tail cuff method) using computerized PowerLab/8SP data-acquisition system (AD Instruments). Whatman phosphocellulose discs (Fisher), and free radioactivity was removed by repeated washings with 75 mM phosphoric acid. The amount of radioactivity on the discs was measured by liquid scintillation. The results were expressed as CPM/min/mg protein. 12, 22 PKC activity was determined using the PKC assay kit (Upstate, Lake Placid, NY Levels. ROCK-II is considered to be the primary isoform of ROK involved in the RhoA/ROKrelated pathway in the smooth muscle contraction. Levels of ROCK-II were determined using Western blot analysis. For this, first, tissue lysates of the IAS and RSM and protein extracts were prepared as described before. [29] [30] [31] Then, 20 µg of proteins were separated by 7.5% SDS g of proteins were separated by 7.5% SDS-PAGE and electrophoretically transferred onto a nitrocellulose membrane (NCM). The NCM was soaked overnight at 4ºC in Tris-buffered saline with Tween (TBS-T; composed of: 20 mM
Drug
Tris pH 7.6, 137 mM NaCl, and 0.1% Tween-20) containing 5% nonfat dry milk. The NCM was then incubated with the primary antibodies diluted in TBS-T containing 1% milk (1:1000 for ROCK-II and 1:20,000 for -actin) for 1h at room temperature. After washing with TBS-T three times, the NCM was incubated with the horseradish peroxidase conjugated species-specific secondary antibody. The NCM was washed with TBS-T and the corresponding bands were Ms. No. GaASTRO-D-06-00128
visualized with enhanced chemiluminescence substrate using the SuperSignal® West Pico Chemiluminescent Substrate (Pierce, Rockford, IL) and captured on X-ray film. Bands corresponding to different proteins on X-ray films were scanned and their relative densities determined by using Image-Pro Plus 4.0 software (Media Cybernetics).
[Ca 2+ ] i levels of the IAS smooth muscle strips were measured using a JASCO calcium analyzer (model CAF-100, JASCO, Inc., Easton, MD) using Fura-2 AM (Molecular Probes, Eugene, OR) as the fluorescent indicator, following the method of Grynkiewictz et al., 35 with specific modifications. 36 R min and R max were determined by treating the tissues with EGTA (3 mM) and Triton X-100 (0.4%), respectively, at the end of each experiment.
Confocal Microscopy. The SMC were cultured in DMEM medium with 10% fetal bovine serum, 5% penicillin-Streptomycin, 50 µg/ml gentamycin, and 2 µg/ml Amphotericin B on Lab- were detected separately and overlay images were generated automatically by the imaging software.
Data Analysis. Data are presented as means ± standard error for the number of animals indicated. Western blot data were normalized to smooth muscle -actin (relative density).
When comparing two groups, an unpaired Student's t test was used. CRCs were analyzed using two way ANOVA test. 
Drugs and
Comparison of ROK activity in the IAS vs. RSM in the Basal State and Following Y 27632.
Actual levels of ROK activity were found to be significantly higher in the IAS vs. RSM (*; p < 0.05; n = 4; Figure 5A ). There was a close relationship between the fall in the IAS tone and the 
DISCUSSION
The studies show that the basal tone in the IAS is critically dependent on RhoA/ROK.
Selectivity and potency of the ROK inhibition in causing IAS relaxation without significant side effects, and its effectiveness in the hypertensive IAS suggest a therapeutic potential of this approach in certain conditions associated with the hypertensive IAS.
The relaxant effect of ROK inhibition works directly at the SMC due to the lack of effect of different neurohumoral inhibitors and the neurotoxin TTX, and by the demonstration of the effects in the SMC. It is well known that NO is the major inhibitory mediator of the IAS Ms. No. GaASTRO-D-06-00128 relaxation in response to NANC nerve stimulation. 5, 23, 28, 37 However, RhoA/ROK-mediated smooth muscle relaxation of the IAS is independent of the NOS pathway since the NOS inhibitor L-NNA failed to modify this effect.
RhoA/ROK are known to be present throughout the SMC, and during the sustained phase of the contraction they translocate to the periphery of the SMC for the ROK activation. ROCK-II is also present in higher levels in the IAS than in the RSM at the translational levels as
shown by Western blot analysis ( Figure 5C ). Data suggest that RhoA/ROK translocation is highly selective and is characteristic of the IAS SMC in the basal state. In addition, our preliminary studies suggest that pretreatment of the IAS SMC with constitutively active RhoA mutant (RhoA V14 ) 22 causes an increase in the ROK activity and shortening of the SMC (data not shown). The ROK inhibitor was found to be selective in its mechanism of action since it does Ms. No. GaASTRO-D-06-00128 not affect the basal levels of [Ca 2+ ] i and PKC activity.
Taken together, the data suggest that RhoA/ROK play a critical role in the maintenance of basal tone in the IAS. Increase in the [Ca 2+ ] i and MLCK activity may be important in the initial (phasic) contraction of smooth muscle rather than in the maintenance of tone. PKC has been speculated to play a role in the tonic contraction of certain smooth muscles, 10,13 however its exact role in the basal tone of the IAS is not known. A part of PKC-mediated effect is dependent on MLCP inhibition via P-CPI-17, which also is one of the mechanisms of action of RhoA/ROK as stated above. 39 Whether or not there is any overlap between these events is not known.
RhoA/ROK have been suggested to play an important role in the etiology and in the therapy of cardiovascular hypertension. 40 The role of RhoA/ROK upregulation in the hypertensive IAS or in the hypermotility of other gastrointestinal smooth muscles has not been investigated. A hypertensive IAS accompanied by inadequate relaxation is a prominent pathophysiological finding of Hirschsprung's disease, hemorrhoids and anal fissures.
5,15,41
The therapeutic potential of ROK inhibitor in the IAS dysfunction associated with the hypertensive IAS is important from two standpoints. Firstly, as shown by the present data, such agents cause IAS relaxation independent of the NOS/cGMP pathway since relaxation still remains intact in the presence of NOS inhibition. It is thought that one of the underlying causes of the sphincteric smooth muscle hypertension may be the lack of NOS-containing myenteric inhibitory neurons. The successful effect of the PDE inhibitors relies on the inhibition of cGMP breakdown causing an increase in the cGMP levels. 43 According to recent studies, the effect of cGMP, in turn, depends on ROK inactivation. 
